4
Colorectal cancer (CRC) is preventable and is one of few cancers for which there is considerable evidence that screening is effective and cost-effective 1, 2 . Colonoscopy allows the detection and removal of precursor polyps during the same session and is the final common pathway for other screening modalities; these characteristics have contributed to its position as the dominant CRC screening modality in the US. However, colonoscopy requires considerable human and financial resources 3, 4 , and the need to balance these constraints with effectiveness has increased interest in strategies where colonoscopy is used selectively after initial testing with one of the other modalities. Sigmoidoscopy is an attractive option because it is more straightforward to perform, is less burdensome, and is associated with lower risk for harm than colonoscopy. Randomized controlled trials [5] [6] [7] and meta-analyses 8, 9 have shown that flexible sigmoidoscopy decreases CRC incidence and mortality, supporting its endorsement by major guideline organizations 1 . Sigmoidoscopy effectively decreases distal CRC incidence and mortality; however, its effect on right-sided CRC depends on the colonoscopy referral strategy in place. The 4 large randomized trials of screening sigmoidoscopy [5] [6] [7] 10 have employed different criteria to refer patients to colonoscopy, but all are based on the premise that the risk of advanced neoplasia in the proximal colon can be predicted according to findings in the distal colon, allowing the adjudication of colonoscopy referrals based on the presence and characteristics of polyps found at sigmoidoscopy 11 . In this context, the term "advanced neoplasia" has been used to refer mainly to lesions on the spectrum of the adenoma-carcinoma sequence, including invasive cancer and advanced adenomas (size ≥ 10 mm or presence of high-grade dysplasia or significant villous components on histology). Indeed, the studies which supported this approach [12] [13] [14] [15] were performed at a time when it was thought that the great majority of colon cancers arose from precursor conventional adenomas via the chromosomal instability pathway. However, it is now recognized that nearly one-third of CRCs arise through the serrated pathway, which is characterized by mutations in the BRAF gene, high levels of methylation of promoter CpG islands (CIMP-high), and in which the sessile serrated adenoma/polyp (SSA/P) is the principle precursor lesion [16] [17] [18] . Serrated lesions can be challenging to visualize because of their subtle morphologic characteristics, and are more likely to be overlooked than conventional adenomas 19, 20 . These features likely account for the fact that the serrated pathway is a disproportionate contributor to interval CRC (CRC diagnosed relatively soon after colonoscopy). Cancers associated with the serrated pathway tend to occur in the proximal colon and their molecular signature overlaps significantly with interval CRC [21] [22] [23] .
The study of serrated lesions has been complicated by evolving definitions and nomenclature, leading to significant inter-observer variability in the histologic differentiation of subtypes of serrated polyps, notably between SSA/P and hyperplastic polyps. The World Health
Organization (WHO) has recently updated the classification of serrated colorectal lesions 18 .
While it is recognized that distal colorectal adenomas are a marker of advanced proximal conventional adenomatous neoplasia, it is not known whether the same applies to important proximal serrated lesions, specifically those higher-risk serrated lesions which warrant more intensive surveillance 16, 24 . This issue is of relevance for CRC screening strategies which employ sigmoidoscopy as the initial test and refer patients to colonoscopy based on distal findings. Such approaches are based on the assumption that the relevant target proximal colon lesions are predominantly adenoma-based, an assumption which does not take into account serrated lesions and their significant contribution to the pathogenesis of CRC. To help understand whether distal colorectal findings are predictive of advanced serrated lesions in the proximal colon, we analyzed data from a large group of average-risk patients who had undergone screening colonoscopy by an endoscopist with high detection rates of adenomatous and serrated polyps, combined with review of histology by an expert pathologist with specific interest in serrated polyps, using the WHO consensus guidelines. history of inflammatory bowel disease, family history of familial adenomatous polyposis, surveillance colonoscopy after polypectomy or CRC resection), were excluded. The proximal colon was defined as cecum, ascending colon, and transverse colon, and the distal colon as splenic flexure, descending colon, sigmoid colon, and rectum. During the interval in which the colonoscopies were performed, the study colonoscopist did not systematically remove all diminutive hyperplastic appearing lesions from the rectosigmoid colon, particularly in patients who had numerous such lesions.
METHODS

This
For the pathology review, we identified all serrated polyps proximal to the sigmoid colon, and serrated polyps >5mm in the rectum or sigmoid colon. Rectosigmoid serrated polyps ≤ 5 mm are overwhelmingly hyperplastic and are not considered to have malignant potential 16, 24 .
Pathology slides were retrieved and reviewed by an experienced GI pathologist (DCS) who was blinded to polyp anatomic location, shape, size, and initial histopathological diagnosis. Serrated polyps were categorized using the WHO classification 18 into hyperplastic polyps (HP), sessile serrated polyps without (SSA/P) and with cytological dysplasia (SSA/P-CD), and traditional serrated adenomas (TSA). SSA/P was diagnosed if a serrated lesion had at least one crypt showing evidence of abnormal proliferation and maturation as evidenced by mature cells at the base of the crypt associated with a dilated, boot or anchor shape and/or excess crypt serration near the base. A diagnosis of HP required that all crypts show normal maturation toward the surface with a normally located basal proliferative zone. For the primary analysis, we targeted serrated lesions which are considered to be at higher risk for progression to cancer, warranting colonoscopic surveillance intervals similar to those of advanced conventional adenomas 16, 24 .
We refer to these lesions as "advanced serrated lesions" (ASL), grouping SSA/P-CD, SSA/P ≥ 10 mm, or TSA. We performed a secondary analysis to determine the odds of any proximal 
Statistical analysis
Descriptive statistics were used to characterize patient demographic features, and to determine the prevalence of proximal and distal colon polyps stratified by patient sex. The number of patients in whom the most advanced lesion was ACN, and the number of patients in whom the most advanced lesion was ASL, were determined. The prevalence of proximal ASL and ACN based on distal colorectal findings was calculated. Multivariable logistic-regression analysis was performed to determine the age-and sex-adjusted odds of advanced proximal adenomatous and serrated lesions, with patients without distal polyps as the reference group.
Based on the overall sample size of 1910 patients, we determined that the study had 80%
power to detect an odds ratio of 2.5 for distal polyp as a predictor of ASL or ACN, using a logistic regression model with age and sex as covariates.
RESULTS
The were female. The number of patients with at least one conventional adenoma was 914 (47.8%), and the number of patients with at least one serrated lesion (includes HP, SSA/P, and TSA) was 688 (36.0%). The corresponding detection rates for advanced conventional adenoma and advanced serrated lesions were 7.4% and 3.0%, respectively. Overall, distal, and proximal colon findings and patient characteristics are shown in Table 1 . Five cancers were diagnosed, 3
in the proximal colon and 2 in the distal colon. There were 52 patients (2.8%) with proximal ASL, and 99 (5.1%) with proximal ACN (one patient had both proximal ASL and ACN). Table 2 lists the subcategories of serrated lesions in patients with proximal and distal ASL. Among the 99 patients with proximal ACN, 61 had at least one TA ≥ 10 mm, 40 had at least one adenoma with villous histology, 9 had at least one adenoma with high-grade dysplasia, and 3 had invasive cancer.
Of 52 patients with proximal ASL, 27 (52%) had no distal polyps removed; of 99 patients with proximal ACN, 40 (40%) had no distal polyps. The age-and sex-adjusted odds of advanced proximal adenomatous and serrated lesions according to distal findings are detailed in Table 3 . Age and type of distal neoplasia (except non-advanced serrated lesions) were associated with proximal ACN. Conversely, only patient age was significantly associated with proximal ASL. There were no significant associations between distal polyps and proximal ASL.In secondary analyses (Table 4) , presence of a distal SSA/P was the lone factor associated with a proximal SSA/P. There were no significant associations with either age or gender.
DISCUSSION
In this study, average-risk patients 50 years of age or older with distal colorectal polyps were no more likely to harbor advanced serrated lesions in the proximal colon than patients without distal colorectal polyps. In addition, more than half of patients with advanced proximal serrated lesions had no polyps in the distal colon.
Our findings extend and update those studies which addressed similar questions, with focus on proximal advanced conventional adenomas. 
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, we found similar relationships between advanced proximal adenomatous neoplasia, and patient age and distal colorectal findings. Additionally, 40% of patients with proximal ACN in our cohort had no distal colorectal findings, which is comparable to previous reports 12 . However, previous studies did not evaluate the association with proximal advanced serrated lesions. We found only patient age to be significantly associated with proximal ASL, while sex and type of distal colorectal neoplasia were not. The proportion of patients with proximal ASL and no distal colorectal polyps was 52%, exceeding the proportion of patients with proximal ACN and no distal colorectal polyps.
These findings are relevant for CRC screening strategies which employ sigmoidoscopy as a "gateway" test, and triage patients to colonoscopy based on findings at sigmoidoscopy.
Distal colorectal findings are associated with the risk of proximal advanced adenomatous neoplasia and can be used to tailor screening recommendations and colonoscopy referrals based on evidence-based estimates of the risk of proximal ACN
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. However, the observation that patients with distal colorectal polyps are no more likely to harbor advanced serrated lesions in the proximal colon than patients without distal colorectal polyps is concerning. For example, a patient with no polyps at sigmoidoscopy who is not referred for a follow-up colonoscopy based exclusively on the estimated risk of advanced ACN, could be harboring significant serrated lesions in the proximal colon which would go undetected. The implications of the lack of association between distal polyps and proximal ASL risk on the relative effectiveness of endoscopic screening strategies are not clear, but may be substantial given the disproportionate contribution of the serrated pathway to proximal and interval CRC. The observation that increasing age was associated with the risk of proximal ASL warrants additional comment.
Epidemiologic studies have shown a rightward shift in the distribution of CRC which may be related to population aging, and proximal colon cancer is associated with molecular features which increase with age and are linked to the serrated pathway (such as methylation and microsatellite instability) 26, 27 . Thus, screening colonoscopy may be more appropriate than a sigmoidoscopy-first approach in older age groups from the standpoint of detection of advanced proximal serrated lesions. Previous work has shown that tailoring CRC screening by quantifying the risk of proximal ACN is feasible, and allows the identification of low risk groups (such as younger women) who could undergo sigmoidoscopy instead of colonoscopy 25 . Our study sample size did not allow us to conduct similar subgroup analyses. Future studies with larger sample sizes should incorporate advanced serrated lesions as a relevant CRC prevention target, as this would help further refine current tailoring and risk-stratification strategies, notably by identifying patient groups at lower risk for proximal ASL.
An important feature of our study is the combination of the endoscopic findings of colonoscopies performed by a high level detector, with a review of serrated polyps by an experienced pathologist using the most recent consensus guidelines. This approach is advantageous for 2 main reasons: First, previous studies reporting prevalence rates of serrated lesions in fact reflected the mean detection rates of endoscopists with highly variable detection of serrated lesions. Restricting the analysis to a single high-level detector allows the derivation of more precise estimates of the relative risks of proximal advanced serrated and adenomatous neoplasms based on distal colorectal findings in the same cohort of average-risk patients.
Second, the histopathologic review of serrated polyps by a single experienced pathologist using the most recent WHO consensus guidelines overcomes the issue of variable pathological criteria to define SSA/P.
Our study has limitations which require additional discussion. First, the definition we used for advanced serrated lesions is empiric, and is based on consensus guidelines which have identified SSA/P with cytological dysplasia, SSA/P ≥ 10 mm, and TSA as equivalent to high-risk conventional adenomas which require more intensive post-polypectomy surveillance 24 .
The evidence supporting the concept of advanced serrated lesions is less robust than that for advanced conventional adenomatous neoplasia, and awaits further data from well-designed longitudinal studies. However, using proximal SSA/P regardless of size or presence of cytological dysplasia as the relevant target lesion, also showed no significant association between distal findings and proximal SSA/P, with the exception of distal SSA/P group. In this regard, the study colonoscopist did not systematically remove all diminutive hyperplastic appearing polyps from the rectosigmoid colon. Thus, we could have missed a significant association between distal colon hyperplastic and proximal ASL, or between distal hyperplastic polyps and any proximal SSA/P, or between distal SSA/P and proximal serrated endpoints, and any missed associations of distal and proximal serrated polyps could have resulted from either an insufficient sample size or incomplete clearing of distal colon hyperplastic appearing polyps.
We recommend additional study of the association of distal colon and proximal serrated lesions.
Second, although the overall sample size was large, the number of proximal ASL and ACN "events" was relatively small, precluding certain subgroup analyses; for example, we could not determine the odds of proximal ACN or ASL for the subgroup with distal ASL with precision, because the latter included only 7 patients. However, we do not believe that the proximal ASL prevalence in our study to be a limitation: the proximal ACN prevalence rates are comparable to those reported in other similar studies 12 , and our proximal ASL rates are thus likely more reflective of the actual prevalence of these lesions in average-risk cohorts.
Third, as with previous studies, our study's cross-sectional design and the database on which it is based limited our ability to account for relevant clinical information such as bodymass index, tobacco use, and use of NSAIDs, which may influence individual patients' risk for CRC. Finally, distal colorectal findings at sigmoidoscopy were estimated based on findings at colonoscopy. The depth of insertion at sigmoidoscopy may vary in clinical practice; however, we considered sigmoidoscopy to be complete and the splenic flexure reached in all instances, an assumption which is similar to previous studies.
In summary, we found that distal colon adenomas, which are the clinically accepted indicators for colonoscopy when detected at sigmoidoscopy, were not associated with advanced proximal colon serrated lesions. A policy of referral for colonoscopy only for distal colon conventional adenomas detected by screening flexible sigmoidoscopy will likely fail to detect important proximal serrated lesions. Further, more than half of patients with advanced proximal serrated lesions had no polyps in the distal colon. Taken together, to the extent that detection of proximal advanced serrated lesions is important to colon cancer prevention, our findings favor screening colonoscopy over sigmoidoscopy, especially with increasing age. Distal colon nonadvanced serrated lesions as a class were associated with any proximal colon SSA/P. This suggests that distal colon hyperplastic polyps (or distal serrated lesions collectively), traditionally considered to have no importance when detected during screening flexible sigmoidoscopy, may 13 be a signal for proximal colon SSA/P. Additional evaluation of this potentially important association, to determine which (if any) subgroups of distal serrated lesions are associated with proximal serrated findings warrants further evaluation. 
